Electra Therapeutics, Inc. (ETRA) KPIs and segments
ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$8.35+0.04 (+0.48%)
Close on Nov 17, 2026Market cap $524.94MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Electra Therapeutics's business
Coming soon
This tab will track the numbers specific to Electra Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?